Evaluation of apigenin using in vitro cytochalasin blocked micronucleus assay

Toxicology in Vitro

Volumn 20, Issue 7, 2006, Pages 1168-1172

  Noel, Sanjeev ^a   Kasinathan, Madhu ^a   Rath, Srikanta Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Apigenin; CBMN assay; Cytochalasin B; Genotoxicity; Human peripheral lymphocytes; Micronucleus

Indexed keywords

APIGENIN; CLASTOGEN; CYTOCHALASIN; FLAVONOID; MUTAGENIC AGENT;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE; MICRONUCLEUS TEST; NORMAL HUMAN; OXIDATION; PARAMETER;

APIGENIN; CYTOCHALASIN B; CYTOKINESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYMPHOCYTES; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MITOMYCIN; REPRODUCIBILITY OF RESULTS;

EID: 33746017423     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.03.007     Document Type: Article

References (29)

1. Ahmed M.S., Ramesh V., Nagaraja V., Parish J.H., and Hadi S.M. Mode of binding of quercetin to DNA. Mutagenesis 9 (1994) 193-197
2. Boos G., and Stopper H. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol. Lett. 116 (2000) 7-16
3. Choi J.S., Park K.Y., Moon S.H., Rhee S.H., and Young H.S. Antimutagenic effect of plant flavonoids in the Salmonella assay system. Arch. Pharma. Res. 17 (1994) 71-75
4. Christine F.S., and Smith M.T. Potential health impacts of excessive flavonoid intake. Free Radical Bio. Med. 29 (2000) 375-383
5. Czeczot H., Tudek B., Kusztelak J., Szymczyk T., Dobrowolska B., Glinkowska G., Malinowski J., and Strzelecka H. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat. Res. 240 (1990) 209-216
6. Fernandez-Botlan R., and Vetvick V. Methods in Cellular Immunology (1995), CRC Press, Boca Raton, Florida p. 6
7. Fimognari C., Berti F., Cantelli-Forti G., and Hrelia P. Effect of cyanidin 3-O-beta-glucopyranoside on micronucleus induction in cultured human lymphocytes by four different mutagens. Environ. Mol. Mutagen. 43 (2004) 45-52
8. Galati G., and O'Brien P.J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radical Bio. Med. 37 (2004) 287-303
9. Hirano T., Oka K., Kawashima E., and Akiba M. Effects of synthetic and naturally occurring flavonoids on mitogen-induced proliferation of human peripheral-blood lymphocytes. Life Sci. 45 (1989) 1407-1411
10. Kobayashi T., Nakata T., and Kuzumaki T. Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett. 176 (2002) 17-23
11. Miller B., Albertini S., Locher F., Thybaud V., and Lorge E. Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: industrial experience. Mutat. Res. 392 (1997) 45-59
12. Miyazawa M., and Hisama M. Antimutagenic activity of flavonoid from Chrysanthemum morifolium. Biosci. Biotechnol. Biochem. 67 (2003) 2091-2099
13. Peterson J., and Dwyer J. Flavonoids: dietary occurrence and biochemical activity. Nutr. Res. 18 (1998) 1995-2018
14. Popp R., and Schimmer O. Induction of sister-chromatid exchanges (SCE), polyploidy, and micronuclei by plant flavonoids in human lymphocyte cultures. A comparative study of 19 flavonoids. Mutat. Res. 246 (1991) 205-213
15. Rithidech K.N., Tungjai M., and Whorton E.B. Protective effect of apigenin on radiation-induced chromosomal damage in human lymphocytes. Mutat. Res. 585 (2005) 96-104
16. Rosenberg R.S., Grass L., Jenkins D.J., Kendall C.W., and Diamandis E.P. Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines. Biochem. Biophys. Res. Commun. 248 (1998) 935-939
17. Sampson L., Rimm E., Hollman P.C., de Vries J.H., and Katan M.B. Flavonol and flavone intakes in US health professionals. J. Am. Diet. Assoc. 102 (2002) 1414-1420
18. Silva I.D., Gaspar J., Gomes da Costa G., Rodrigues A.S., Laires A., and Rueff J. Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents. Chem. Biol. Interact. 124 (2000) 29-51
19. Snyder R.D., and Gillies P.J. Evaluation of the clastogenic, DNA intercalation, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ. Mol. Mutagen. 40 (2002) 266-276
20. Solimani R., Bayon F., Domini I., Pifferi P.G., Todesco P.E., Marconi G., and Samori B. Flavonoid-DNA interaction studied with flow linear dichroism technique. J. Agri. Food Chem. 43 (1995) 876-882
21. Stopper H., Full M., Helbig R., and Speit G. Micronucleus induction by neocarzinostatin and methyl methanesulfonate in ionizing radiation-sensitive Chinese hamster V79 cell mutants. Mutat. Res. 383 (1997) 107-112
22. Stopper H., Schmitt E., and Kobras K. Genotoxicity of phytoestrogens. Mutat. Res. 574 (2005) 139-155
23. Strick R., Strissel P.L., Borgers S., Smith S.L., and Rowley J.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. USA 97 (2000) 4790-4795
24. Thomas P., Umegaki K., and Fenech M. Nucleoplasmic bridges are a sensitive measure of chromosome rearrangement in the cytokinesis-block micronucleus assay. Mutagenesis 18 (2003) 187-194
25. Virgilio A.L., Iwami K., Wätjen W., Kahl R., and Degen G.H. Genotoxicity of the isoflavones genistein, daidzein and equol in V79 cells. Toxicol. Lett. 151 (2004) 151-162
26. Way T.D., Kao M.C., and Lin J.K. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 279 (2004) 4479-4489
27. Wei H., Tye L., Bresnick E., and Birt D.F. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res. 50 (1990) 499-502
28. Yamashita N., and Kawanishi S. Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin. Free Radical Res. 33 (2000) 623-633
29. Yamashita Y., Kawada S.-Z., and Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem. Pharmacol. 39 (1990) 737-744